Physician profile
Michael T Archdeacon
NPI 1699723247
$2,250,941.01
in general payments reported to CMS, 2019-2025
4 companies · $1.0M in 2025
The $1.0M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176K · 2020: $153K · 2021: $202K · 2022: $201K · 2023: $247K · 2024: $236K · 2025: $1.0M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.4M · Consulting Fee: $133K · Travel and Lodging: $17K · Food and Beverage: $3,211 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,365,857.77 |
| Consulting Fee | $133,365.00 |
| Travel and Lodging | $16,831.55 |
| Food and Beverage | $3,210.84 |
| Education | $238.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,249,969.12 | 2019-2025 | Pangea, Pelvis II, Pro |
| Depuy Synthes Sales INC. | $458.13 | 2022-2024 | Expert Nail, Na |
| Smith+Nephew, INC. | $424.65 | 2019-2024 | Evos, Trigen Intertan |
| Zimmer Biomet Holdings, INC. | $89.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Archdeacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.